European Biotech Acquisition Corp. Quarterly General and Administrative Expense in USD from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
European Biotech Acquisition Corp. quarterly/annual General and Administrative Expense history and growth rate from Q1 2021 to Q4 2022.
  • European Biotech Acquisition Corp. General and Administrative Expense for the quarter ending December 31, 2022 was $1.12M, a 127% increase year-over-year.
  • European Biotech Acquisition Corp. General and Administrative Expense for the twelve months ending December 31, 2022 was $2.59M, a 184% increase year-over-year.
  • European Biotech Acquisition Corp. annual General and Administrative Expense for 2022 was $2.59M, a 184% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $2.59M $1.12M +$629K +127% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $1.97M $955K +$762K +394% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.2M $312K +$178K +132% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.03M $203K +$113K +126% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $912K $494K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $193K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $135K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $89.9K Jan 8, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.